Umbra Companies Inc (UCIX)

Currency in USD
0.2500
+0.0500(+25.00%)
Closed·
UCIX Scorecard
Full Analysis
Significant return over the last week
UCIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.25000.2500
52 wk Range
0.05884.7300
Key Statistics
Prev. Close
0.25
Open
0.25
Day's Range
0.25-0.25
52 wk Range
0.0588-4.73
Volume
911
Average Volume (3m)
6.23K
1-Year Change
-92.9%
Book Value / Share
-0.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
UCIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Umbra Companies Inc Company Profile

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company’s lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. It also provides Patient Pure X, an autologous blood-derived biologic technology, that helps the body’s natural ability to decrease cellular inflammation and promote tissue healing. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROW X, a professional-grade formula that delivers a concentrated dose of topical exosomes that help support follicular function; ZEO GROW BOOST; and EXO FOLLICLE FUEL. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is headquartered in Davie, Florida.

Employees
20

Compare UCIX to Peers and Sector

Metrics to compare
UCIX
Peers
Sector
Relationship
P/E Ratio
−2.2x−1.3x−0.6x
PEG Ratio
−0.19−0.030.00
Price/Book
−5.1x1.7x2.6x
Price / LTM Sales
2.3x39.7x3.3x
Upside (Analyst Target)
-188.1%39.5%
Fair Value Upside
Unlock6.9%4.9%Unlock

Earnings

Latest Release
Jun 16, 2025
EPS / Forecast
-0.22 / --
Revenue / Forecast
1.15M / --
EPS Revisions
Last 90 days

UCIX Income Statement

FAQ

What Stock Exchange Does Umbra Companies Trade On?

Umbra Companies is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Umbra Companies?

The stock symbol for Umbra Companies is "UCIX."

What Is the Umbra Companies Market Cap?

As of today, Umbra Companies market cap is 12.60M.

What Is Umbra Companies's Earnings Per Share (TTM)?

The Umbra Companies EPS (TTM) is -0.76.

From a Technical Analysis Perspective, Is UCIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Umbra Companies Stock Split?

Umbra Companies has split 2 times.

How Many Employees Does Umbra Companies Have?

Umbra Companies has 20 employees.

What is the current trading status of Umbra Companies (UCIX)?

As of 21 Aug 2025, Umbra Companies (UCIX) is trading at a price of 0.25, with a previous close of 0.25. The stock has fluctuated within a day range of 0.25 to 0.25, while its 52-week range spans from 0.06 to 4.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.